Augtyro™ (repotrectinib)
for Lung Cancer

Augtyro (repotrectinib) is a next-generation tyrosine kinase inhibitor used to treat ROS1-positive non-small cell lung cancer (NSCLC) and certain solid tumors. In these cancers, the ROS1 gene fuses with another gene, leading to uncontrolled cell growth. Augtyro works by blocking ROS1 and related kinases, helping to slow cancer progression and reduce tumor size.

Heart